# PORTOLA PHARMACEUTICALS INC

PORTOLA PHARMACEUTICALS INC is a company headquartered in South San Francisco, CA, United States.

## Company overview

- **Legal name:** PORTOLA PHARMACEUTICALS INC
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** South San Francisco, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001269021

## About

PORTOLA PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001269021, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-02-28, it reported annual revenue of USD 116,640,000; net income of USD -290,663,000; total assets of USD 578,483,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $116.6M (USD 116,640,000)
- **Net income:** -$290.7M (USD -290,663,000)
- **Total assets:** $578.5M (USD 578,483,000)
- **Cash and equivalents:** $215.2M (USD 215,229,000)
- **Operating cash flow:** -$237.9M (USD -237,923,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $40.1M (USD 40,130,000)
- **Net income:** -$350.2M (USD -350,223,000)
- **Total assets:** $386.4M (USD 386,419,000)
- **Cash and equivalents:** $139.0M (USD 138,951,000)
- **Operating cash flow:** -$326.1M (USD -326,058,000)

### FY2017 (period ended 2017-12-31)

- **Net income:** -$286.1M (USD -286,090,000)
- **Total assets:** $571.7M (USD 571,676,000)
- **Cash and equivalents:** $181.6M (USD 181,568,000)

### FY2016 (period ended 2016-12-31)

- **Net income:** -$269.0M (USD -269,043,000)
- **Total assets:** $343.4M (USD 343,436,000)
- **Cash and equivalents:** $188.5M (USD 188,480,000)

## Recent SEC filings

- Form 8-K — filed 2020-07-02 — period 2020-07-02 — FORM 8-K
- Form 8-K — filed 2020-06-17 — period 2020-06-12 — 8-K
- Form 8-K — filed 2020-06-15 — period 2020-06-12 — 8-K
- Form 10-Q — filed 2020-05-11 — period 2020-03-31 — 10-Q
- Form 8-K — filed 2020-05-11 — period 2020-05-11 — FORM 8-K
- Form SC 13D — filed 2020-05-08 — SC 13D
- Form 8-K — filed 2020-05-07 — period 2020-05-04 — FORM 8-K
- Form 8-K — filed 2020-05-05 — period 2020-05-05 — FORM 8-K
- Form DEF 14A — filed 2020-04-20 — period 2020-06-12 — DEF 14A
- Form 8-K — filed 2020-04-09 — period 2020-04-03 — 8-K
- Form 10-K — filed 2020-02-28 — period 2019-12-31 — 10-K
- Form 8-K — filed 2020-02-26 — period 2020-02-26 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/portola-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology